A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- In Once-Redlined City Neighborhoods, Ambulances Still Lag Behind.
- How Alcohol Ads in Your Feed May Lead to Alcohol in Your Glass.
- Launch of NJIT’s B.S. in Enterprise AI Cultivates Next-Generation Tech Talent.
- Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers.
- NJACTS Community Engagement Core Available Services
Categories
- Community (2,400)
- Covid (993)
- CTO Events (6)
- News (3,038)
- Pilots (21)